Reportlinker Adds Cancer Reports Bundle

NEW YORK, May 3, 2011 /PRNewswire/ — Reportlinker.com announces
that a new market research report is available in its
catalogue:

Cancer Reports Bundle

http://www.reportlinker.com/p0488682/Cancer-Reports-Bundle.html

The Cancer Reports Bundle includes the following TriMark
Publications reports at a 15% discount off the individual
reports being purchased separately:

– Biomarker Technology Platforms for Cancer Diagnoses and
Therapies.

– Cancer Cell Therapy Markets.

– Cancer Diagnostic Testing World Markets.

– Cancer Therapeutics Markets.

– Cancer Vaccines Markets.

– Companion Diagnostics in Personalized Medicine and Cancer
Therapy.

– Cytology and HPV Testing World Markets.

Below are summaries of each report.

– Biomarker Technology Platforms for Cancer Diagnoses and
Therapies

Until superior therapeutic treatments are developed to prevent,
treat and cure cancer, the best means of reducing mortality and
morbidity in a disease this complex is early detection and
diagnosis. In the major solid cancer types such as lung, breast,
colon and prostate, long-term survival rates drop precipitously
once metastatis has occurred. The case is clear for development of
biomarkers for early detection and screening tests for diseases
such as breast, colon, ovarian and lung cancer. In addition,
diagnostic measurement of cancer disease progression is essential
to successful disease management. For these reasons, development of
new and effective biomarkers for cancer detection and diagnosis is
central to the cancer problem. The use of nucleic acid biomarker
diagnostics have begun to answer these questions. Protein
biomarkers are also useful. The purpose of this T

‘/>”/>

SOURCE